MIVI Neuroscience, (MIVI) is an innovative medical device company that aims to achieve life-giving results for an increasing number of patients experiencing acute ischemic stroke (AIS). We accomplish this through proprietary technology designed in collaboration with physicians to vastly improve the safety and efficacy of interventional AIS therapy.
Location: United States, Minnesota, Eden Prairie
Employees: 11-50
Total raised: $35M
Founded date: 2013
Investors 2
| Date | Name | Website |
| - | Concord He... | concordhp.... |
| - | Perceptive... | perceptive... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.01.2021 | Series B | $35M | - |
Mentions in press and media 1
| Date | Title | Description |
| 21.01.2021 | Mivi Neuroscience Raises Series B Funding | Mivi Neuroscience, an Eden Praire, Minn.-based medical device company focused on improving clinical outcomes for ischemic stroke patients, closed a $35m Series B funding in new money plus the conversion of previously issued convertible note... |